MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Personal Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Personal Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
  •  

AIVITA Biomedical Partners with Guthy-Renker For ROOT of SKIN™ Product Line

IRVINE, Calif. – April 2, 2019 – AIVITA Biomedical, Inc., a biotechnology company specializing in innovative stem cell applications,…

AIVITA Biomedical to Present Biomarker Findings at 2019 AACR Annual Meeting

IRVINE, Calif. – March 28, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

ROOT OF SKIN™ Skincare Line Sets New Sales Record on QVC Japan

IRVINE, Calif. – March 4, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical to Present Cancer Vaccine Data at 2019 ASCO-SITC Clinical Immuno-Oncology Symposium

IRVINE, Calif. – March 1, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial

IRVINE, Calif. – February 21, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Identifies Mechanism to Enhance Patient Response Rate to Next Generation Cancer Stem Cell Immunotherapy

IRVINE, Calif. – February 12, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

ROOT OF SKIN™ Skincare Line Sells Out for Fifth Consecutive Time on QVC Japan

IRVINE, Calif. – February 11, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

Predictive Markers of Survival Identified for Next Generation Cancer Stem Cell Vaccine

IRVINE, Calif. – February 5, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

ROOT OF SKIN™ Skincare Line Sets Records in Fourth Consecutive Sell Out on QVC Japan

IRVINE, Calif. – January 25, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical to Present at Upcoming January Healthcare Conferences

IRVINE, Calif. – January 21, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

  • Previous
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next

AIVITA Biomedical is a biotechnology company developing personalized vaccines that target infectious diseases and tumor-initiating cells — the seed of all cancers — using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development in cancer, infectious disease and other fields.

Recent News

  • AIVITA Biomedical Licenses Novel Skincare Formulations to Global Skincare Retailer LevEllis
  • AIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Join Keynote Panel for AI in Public Health at World Vaccine Congress
  • AIVITA Biomedical Strengthens Board of Directors with Appointment of Ex-Biogen CEO Michel Vounatsos
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Biotech Showcase 2024

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2023 | AIVITA Biomedical, Inc.